[{"Assets_0_Q2_USD":450139000.0,"CommonStockSharesOutstanding_0_Q2_shares":55341113.0,"EarningsPerShareBasic_1_Q2_USD":-1.15,"EarningsPerShareBasic_2_Q2_USD":0.38,"EarningsPerShareDiluted_1_Q2_USD":-1.15,"EarningsPerShareDiluted_2_Q2_USD":0.37,"NetIncomeLoss_1_Q2_USD":-63046000.0,"NetIncomeLoss_2_Q2_USD":21044000.0,"StockholdersEquity_0_Q2_USD":377772000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":54976000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":56176000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":54976000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":54913000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]